Skip to content

Copper-Chelating Tripeptide / Tissue Repair Research Compound / Wound Healing Peptide

Copper Peptides Research — GHK-Cu & Tissue Regeneration

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex; CAS 89030-95-5; MW 340.38 Da) is a naturally occurring copper-chelating tripeptide first isolated from human plasma albumin in 1973 by Loren Pickart. It is found at significant concentrations in human plasma (~200 ng/mL in young adults), saliva, and urine, and declines with age — a pattern that has motivated research into GHK-Cu's roles in wound healing, tissue repair, anti-inflammatory signaling, and skin biology. As a copper tripeptide complex, GHK-Cu carries Cu(II) in a square-planar coordination with the imidazole nitrogen of histidine and the α-amino nitrogens of glycine and histidine — this copper coordination is essential for its biological activity. GHK-Cu is one of the most studied copper peptides in preclinical research and has a well-characterized mechanism across multiple tissue-repair models. Research use only.

Compound identity

Name
Copper Peptides — GHK-Cu Research Hub
Class
Copper-Chelating Tripeptide / Tissue Repair Research Compound / Wound Healing Peptide
Also known as
copper peptide research, GHK-Cu research, copper tripeptide research, copper peptide skin research, GHK copper peptide, glycyl-histidyl-lysine copper, wound healing peptide research, copper binding peptide, GHK-Cu skin regeneration, copper peptide wound healing, skin repair peptide research, copper tripeptide-1

Research context

GHK-Cu's research mechanisms span several distinct biological axes: (1) **Collagen synthesis** — GHK-Cu stimulates collagen synthesis in fibroblast cultures (documented by multiple independent groups) via TGF-β1 upregulation and direct effects on fibroblast collagen gene expression; (2) **Wound healing** — in rodent wound-healing models, topical and systemic GHK-Cu accelerates wound closure, granulation tissue formation, and re-epithelialization; (3) **Angiogenesis** — GHK-Cu stimulates VEGF and FGF-2 expression in fibroblasts and endothelial cells, promoting neovascularization in healing tissue; (4) **Anti-inflammatory effects** — GHK-Cu reduces TGF-β1-driven fibrosis (paradoxically, TGF-β1 at low concentrations stimulates collagen and at high concentrations drives fibrosis — GHK-Cu modulates toward the healing direction); (5) **Antioxidant** — the Cu(II) complex has superoxide dismutase-like activity, scavenging reactive oxygen species in wound environments.

GHK-Cu also has an active research record in skin biology and anti-aging models. Published studies using fibroblast cultures and ex vivo skin models show GHK-Cu upregulates decorin, lumican, and collagen-associated proteoglycans (extracellular matrix components that maintain skin architecture), and stimulates TIMP-1 and TIMP-2 (inhibitors of matrix metalloproteinases that degrade collagen). In vitro studies have also shown GHK-Cu influences gene expression broadly — Pickart et al. and later Maquart's group have published microarray data suggesting GHK-Cu modulates the expression of hundreds of genes involved in tissue remodeling, inflammation, and cell proliferation in fibroblasts. This broad gene-expression footprint is consistent with GHK-Cu's role as a natural tissue-remodeling signal rather than a receptor-targeted compound.

For researchers using GHK-Cu: the compound is typically supplied as the copper(II) complex (blue-green color from Cu(II) coordination). Stability is excellent in lyophilized form; in aqueous solution, pH stability and copper oxidation state maintenance are important (acidic pH preserves Cu(II)). The free peptide GHK (without copper) retains some activity but substantially less in wound-healing and collagen-synthesis assays — copper coordination appears essential for full bioactivity. GHK-Cu should not be confused with GHK (glycyl-histidyl-lysine, the free tripeptide without copper complexation) or with synthetic copper peptides used in cosmetic formulations, which may have different compositions. DMV Research supplies GHK-Cu as a research-grade compound with ≥98% purity by HPLC and mass spectrometry. Research use only.

Frequently asked questions

What is GHK-Cu and what research has studied it?+

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex, CAS 89030-95-5, MW 340.38 Da) is a naturally occurring copper-chelating tripeptide first isolated from human plasma albumin by Loren Pickart in 1973. It is studied for wound healing, collagen synthesis stimulation, angiogenesis, anti-inflammatory effects, and skin tissue repair. Found at ~200 ng/mL in human plasma (young adults); declines with age. Research use only.

How does GHK-Cu stimulate collagen synthesis?+

GHK-Cu stimulates collagen synthesis in fibroblast cultures via multiple mechanisms: upregulation of TGF-β1 (at low, pro-healing concentrations), direct effects on fibroblast collagen gene expression, and upregulation of proteoglycans (decorin, lumican) that support extracellular matrix architecture. The copper(II) coordination appears essential — free GHK peptide without copper has substantially reduced collagen-stimulating activity. Research use only.

What wound healing models have used GHK-Cu?+

Rodent wound-healing models (excisional wound, incisional wound) have shown topical and systemic GHK-Cu accelerates wound closure, granulation tissue formation, and re-epithelialization. In vitro fibroblast scratch assays demonstrate GHK-Cu enhances migration and proliferation. Additional models include chronic wound repair in diabetic rodents (delayed wound healing as a disease model). All research is preclinical; GHK-Cu is not FDA-approved for any therapeutic wound-healing indication. Research use only.

How is GHK-Cu different from free GHK peptide?+

GHK-Cu is the copper(II) complex of the GHK tripeptide — the copper is coordinated in a square-planar complex with the imidazole nitrogen (His) and α-amino nitrogens (Gly, His). This copper coordination is essential for full biological activity. Free GHK (without copper) retains some activity in gene-expression studies but substantially less in wound-healing and collagen-synthesis assays. Research should specify which form is used: GHK-Cu (copper complex, CAS 89030-95-5) vs GHK (free peptide, CAS 49557-75-7). Research use only.

Research use only

All products are intended for laboratory and research use only (RUO) and are not for human consumption, ingestion, or any in-vivo use.

The statements on this page have not been evaluated by the FDA. Copper Peptides — GHK-Cu Research Hub is not intended to diagnose, treat, cure, or prevent any disease. Content is provided for laboratory research reference only.